Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

S. Ettinger, David; E. Wood, Douglas; L. Aisner, Dara; Akerley, Wallace; R. Bauman, Jessica; Bharat, Ankit; S. Bruno, Débora; Y. Chang, Joe; R. Chirieac, Lucian; A. D’Amico, Thomas; M. DeCamp, Malcolm; J. Dilling, Thomas; E. Dowell, Jonathan; Gettinger, Scott; E. Grotz, Travis; A. Gubens, Matthew; Hegde, Aparna; P. Lackner, Rudy; Lanuti, Michael; Lin, Jules; W. Loo, Billy; M. Lovly, Christine; Maldonado, Fabien; Massarelli, Erminia; Morgensztern, Daniel; Ng, Thomas; A. Otterson, Gregory; M. Pacheco, Jose; Pravin Patel, Sandip; J. Riely, Gregory; W. Riess, Jonathan; E. Schild, Steven; A. Shapiro, Theresa; P. Singh, Aditi; Stevenson, James; L. Tam, Alda; Tanvetyanon, Tawee; Yanagawa, Jane; C. Yang, Stephen; Yau, Edwin; M. Gregory, Kristina; Hughes, Miranda

doi:10.6004/jnccn.2022.0025

Public

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Published in Journal of the National Comprehensive Cancer Network • May 1, 2022

Authors:

David S. Ettinger

Douglas E. Wood

Dara L. Aisner

Abstract

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are elig...

Subject

Medicine

Oncology

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!